
Sign up to save your podcasts
Or


We discuss a number of topics in this episode but have a lot of focus on recent FDA breakthroughs, upcoming plans with their lead drug TerXT.
By Max Brennan - Biotech HeadHunterWe discuss a number of topics in this episode but have a lot of focus on recent FDA breakthroughs, upcoming plans with their lead drug TerXT.